Capricor Therapeutics, Inc. (CAPR) financial statements (2020 and earlier)

Company profile

Business Address 8840 WILSHIRE BLVD
BEVERLY HILLS, CA 90211
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:7714161482
Cash and cash equivalents7463682
Short-term investments 38138 0
Other undisclosed cash, cash equivalents, and short-term investments      0
Restricted cash and investments0011 31
Receivables000000 
Other undisclosed current assets0110000
Total current assets:78161814124
Noncurrent Assets
Property, plant and equipment0100000
Intangible assets, net (including goodwill)0000222
Goodwill      2
Intangible assets, net (excluding goodwill)0000220
Regulated entity, other noncurrent assets      0
Deferred costs    00 
Other undisclosed noncurrent assets000000(0)
Total noncurrent assets:1111222
TOTAL ASSETS:89161916146
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1113322
Accounts payable and other accrued liabilities2
Other undisclosed accounts payable and accrued liabilities111332 
Deferred revenue and credits 144 
Other undisclosed current liabilities0000001
Total current liabilities:1125762
Noncurrent Liabilities
Long-term debt and lease obligation   1499 
Long-term debt, excluding current maturities   1499 
Liabilities, other than long-term debt, including:    144
Deferred revenue and credits  14 
Other undisclosed liabilities, other than long-term debt      4
Other undisclosed noncurrent liabilities333410 
Total noncurrent liabilities:3331811144
Total liabilities:4552317206
Stockholders' equity
Stockholders' equity attributable to parent, including:4511(4)(1)(6)(1)
Common stock0000000
Additional paid in capital76716350341616
Accumulated other comprehensive income (loss) 0000 (0)
Accumulated deficit(73)(67)(52)(54)(35)(22) 
Other undisclosed stockholders' equity attributable to parent      (16)
Total stockholders' equity:4511(4)(1)(6)(1)
TOTAL LIABILITIES AND EQUITY:89161916146

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net11211
Gross profit:1234651
Operating expenses(11)(17)(16)(21)(18)(11)(7)
Operating loss:(10)(15)(13)(17)(13)(6)(7)
Nonoperating income (expense)0015(2)(0)(0)(2)
Investment income, nonoperating000000(0)
Interest and debt expense  (0)(0)(0)(0)(0)
Net income (loss):(9)(15)2(19)(13)(6)(9)
Other undisclosed net income (loss) attributable to parent(0) 00000
Net income (loss) available to common stockholders, diluted:(9)(15)2(19)(13)(6)(9)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(9)(15)2(19)(13)(6)(9)
Other undisclosed comprehensive income      0
Comprehensive income (loss):(9)(15)2(19)(13)(6)(9)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)000009
Comprehensive income (loss), net of tax, attributable to parent:(9)(15)2(19)(13)(6)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: